| Datum | Källa | Rubrik | Typ | Alternativ | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-12 | Initiator Pharma | Initiator Pharma’s pudafensine preclinical pharmacology results published in the British Journal of Pharmacology | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-04-12 | Initiator Pharma | Initiator Pharmas prekliniska farmakologiska resultat med pudafensine publiceras i British Journal of Pharmacology | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-02-26 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med Initiator Pharma - Carnegie Investment Bank - 26 feb 2024 | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2024-02-23 | Redeye | Redeye: Initiator Pharma - Q4 2023 – Breathing optimism | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-02-23 | Initiator Pharma | INITIATOR PHARMA: BOKSLUTSKOMMUNIKÉ 2023 | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-02-23 | Initiator Pharma | INITIATOR PHARMA: YEAR END REPORT 2023 | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-02-21 | Initiator Pharma | MAC Clinical Research konverterar sin fordran till aktier i Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-02-21 | Initiator Pharma | MAC Clinical Research converts its receivable into shares in Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-01-23 | Initiator Pharma | Issuance of new shares and directed share buyback, as well as the sale of shares in connection with the long-term incentive program for 2021 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-01-23 | Initiator Pharma | Nyemission och riktat aktieåterköp samt försäljning av aktier i samband med det långsiktiga incitamentsprogrammet för 2021 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-01-08 | Initiator Pharma | Initiator Pharma utvidgar sin position till en bredare franchise inom sexuell hälsa och intensifierar affärsutvecklingsarbetet | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2024-01-08 | Initiator Pharma | Initiator Pharma expands its position to a broader Sexual Health Franchise and intensifies its business development efforts | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-11-13 | Penser Access | Penser Access: Positiv utveckling - mer på agendan i år - Initiator Pharma | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-11-10 | Redeye | Redeye: Initiator Pharma Q3 - A historical quarter | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-11-10 | Initiator Pharma | INITIATOR PHARMA: RAPPORT FÖR TREDJE KVARTALET 2023 | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-11-10 | Initiator Pharma | INITIATOR PHARMA: Q3 2023 REPORT | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-10-18 | Initiator Pharma | Initiator Pharma presenterar på BioStock Life Science Summit den 25 oktober | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-10-10 | Redeye | Redeye: Initiator Pharma - Positive Phase IIb results | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-10-09 | Penser Access | Penser Access: Levererar positiva resultat - Initiator Pharma | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-10-09 | Penser Access | Penser Access: Interview with Initiator Pharma - Erik Penser Bank - Oct 9th 2023 | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-10-06 | Initiator Pharma | Initiator Pharma reports positive statistically significant and clinically relevant Phase IIb efficacy data with pudafensine | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-10-06 | Initiator Pharma | Initiator Pharma rapporterar positiva, statistiskt signifikanta och kliniskt relevanta fas IIb-effektdata för pudafensine | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-09-25 | Initiator Pharma | Utnyttjande i Initiator Pharmas incitamentsprogram LTI2023 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-09-25 | Initiator Pharma | Result of incentive program LTI2023 in Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-09-22 | Penser Access | Penser Access: Interview with Initiator Pharma - Erik Penser Bank - Sep 21st 2023 | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-09-19 | Initiator Pharma | Initiator Pharma announces indication expansion – clinical drug candidates active in models of female sexual dysfunction | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-09-19 | Initiator Pharma | Initiator Pharma meddelar indikationsutvidgning av båda sina kliniska läkemedelskandidater till kvinnor med sexuell dysfunktion | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-08-25 | Redeye | Redeye: Initiator Pharma Q2 2023 - Development progres | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-08-25 | Initiator Pharma | INITIATOR PHARMA: RAPPORT FÖR ANDRA KVARTALET 2023 | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-08-25 | Initiator Pharma | INITIATOR PHARMA: Q2 2023 REPORT | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-08-09 | Initiator Pharma | Initiator Pharma obtains IP2018 patent in Europe for treatment of Erectile Dysfunction and Depression | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-08-09 | Initiator Pharma | Initiator Pharma erhåller patent i Europa för IP2018 mot erektil dysfunktion och depression | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-07-18 | Initiator Pharma | Initiator Pharma announces positive results from pudafensine Phase I pharmacokinetic trial | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-07-18 | Initiator Pharma | Initiator Pharma meddelar positiva resultat från farmakokinetisk fas I-studie med pudafensin | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-07-05 | Initiator Pharma | Slutförande av aktieåterköpsprogram i Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-07-05 | Initiator Pharma | Finalization of share buyback program in Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-06-29 | Initiator Pharma | Initiator Pharma completes recruitment in Phase IIb trial with pudafensine (IP2015) | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-06-29 | Initiator Pharma | Initiator Pharma slutför rekryteringen i fas IIb-studie med pudafensine (IP2015) | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-06-21 | Initiator Pharma | Emission av nya aktier, återköp och försäljning av aktier i samband med långsiktigt incitamentsprogram för 2022 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-06-21 | Initiator Pharma | Issuance of new shares, share buyback and sale of shares in connection with long term incentive program for 2022 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-06-14 | Penser Access | Penser Access: Positiva resultat stärker caset - Initiator Pharma | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-06-05 | Initiator Pharma | Initiator Pharma reports dose-dependent significant efficacy of IP2018 in the placebo-controlled Phase IIa clinical trial of Erectile Dysfunction | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-06-05 | Initiator Pharma | Initiator Pharma rapporterar positiva dosberoende och signifikanta effektdata i den kliniska fas IIa-studien med IP2018 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-31 | Initiator Pharma | BioStock Life Science Spring Summit med Initiator Pharma | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-31 | Initiator Pharma | BioStock Life Science Spring Summit with Initiator Pharma | Pressreleaser | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-30 | Initiator Pharma | Initiator Pharma erhåller det internationella generiska namnet pudafensine för IP2015 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-30 | Initiator Pharma | Initiator Pharma’s IP2015 obtains the International Nonproprietary Name pudafensine | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-26 | Initiator Pharma | Initiator Pharma A/S - Resolutions of the annual general meeting 2023 | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-05 | Redeye | Redeye: Initiator Pharma Q1 report - Countdown to readouts | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-05 | Initiator Pharma | INITIATOR PHARMA: RAPPORT FÖR FÖRSTA KVARTALET 2023 | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-05 | Initiator Pharma | INITIATOR PHARMA: Q1 2023 REPORT | Rapporter | Ladda ner | Visa Stäng | ||||||
|
Rapporter |
INITIATOR PHARMA: Q1 2023 REPORTBusiness highlights in Q1 2023
Business highlights after this reporting period
Financial Highlights
Solidity: equity divided by assets. The Board of Directors have decided that interim reports will be published in English only. Link to the full report |
||||||||||
| 2023-05-03 | Initiator Pharma | Initiator Pharma A/S | Pressreleaser | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-02 | Initiator Pharma | Annual report and Remuneration report 2022 for Initiator Pharma A/S | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
| 2023-05-02 | Initiator Pharma | Årsredovisning och ersättningsrapport 2022 för Initiator Pharma A/S | Rapporter | Ladda ner | Visa Stäng | ||||||
|
|
||||||||||
Kommande händelser
